USANA HEALTH SCIENCES INC(USNA)Stock Analysis

USNA Stock Analysis & AI Quality Score

AI stock analysis and institutional research for USANA HEALTH SCIENCES INC (USNA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores USNA at 40.0/100 on a 32-signal composite quality model, placing it at rank #1,956 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (6.7) and institutional flow (27.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), USANA HEALTH SCIENCES INC reports quarterly revenue of $250.2M, net income of $7.5M, an operating margin of 5.5%. Top institutional holders of USNA by reported 13-F value include BlackRock,, PZENA INVESTMENT MANAGEMENT, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. USNA trades on the NYSE exchange and files with the SEC under CIK 896264. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate USNA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for USANA HEALTH SCIENCES INC directly from SEC EDGAR.